MW-313

N/A

Report date: 2025/11/21 17:29:29

Base Information

Drug NameMW-313
Drug Alias NameMW-313MW313
ClassificationOther
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesMwyngil Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMwyngil Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A